NanoString Technologies is no newcomer to the single-cell genomics market. The firm last year launched a single-cell gene expression assay for use on its nCounter Analysis System. But the company has decided to expand its single-cell genomics offering by partnering with BD Biosciences.

Under an agreement announced last week, NanoString and BD plan to develop a single-cell isolation and analysis workflow by combining BD's FACSJazz Cell Sorting System and NanoString's Single Cell Assay.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.